Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
Evaluation of the Safety and Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter for Peripheral Intravenous (PIV) Insertion in Children, Oncology Patients and Elderly: a Controlled Randomized Trial
Sponsor: C. R. Bard
Terminated
Funding Stopped
Listed as NCT00914069, this NA trial focuses on Vascular Access Complication and remains terminated or withdrawn. Sponsored by C. R. Bard, it has been updated 8 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
May 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — May 2017 [monthly]
Terminated NA
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- C. R. Bard
For direct contact, visit the study record on ClinicalTrials.gov .